(Q58853178)
Statements
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis (English)
Ashutosh D Wechalekar
Hugh J B Goodman
Mark Offer
Philip N Hawkins
Julian D Gillmore
21 September 2006